Swedish Orphan Biovitrum (SOBi) is a medical company dedicated to develop and provide treatments to rare disease patients. The company is based in Solna, Sweden, near the Karolinska Institute. SOBi´s area of interest is rare, potentially life-threatening diseases. Such diseases include diseases affecting the metabolism, inflammatory diseases such as rheumatism or cancer. One of their most successful products is recombinant Factor-8, an enzyme lacking in people suffering from hemophilia.
Mona Sydow-Bäckman is the responsible cell biologist in a number of SOBi´s projects. She trained originally as microbiologist, but has specialized in cell biology since the early 1990s, with her primary focus on the development of assays. She has used the Luciferase Assay Kit from BioThema in several projects, the first one in 2002.